Chang‐Qing Zhu
Quadient (United Kingdom)(GB)MRC Biostatistics Unit(GB)
Publications by Year
Research Areas
Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery, Respiratory Support and Mechanisms, Respiratory and Cough-Related Research
Most-Cited Works
- → FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease(2017)326 cited
- → Intra-arterial blood pressure reference ranges, death and morbidity in very low birthweight infants during the first seven days of life(1999)142 cited
- → Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial(2015)62 cited
- → Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study(2018)57 cited
- → Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD(2021)40 cited
- → Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials(2020)39 cited
- → Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study(2017)35 cited
- → Once-Daily Triple Therapy in Patients with COPD: Patient-Reported Symptoms and Quality of Life(2018)32 cited
- → Preventing clinically important deterioration with single-inhaler triple therapy in COPD(2018)25 cited
- → Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data(2021)24 cited